Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -1.66x is 99% above its 5-year average of -172.48x, near the high end of its 5-year range (-358.13x–-1.66x).
As of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): -1.66x.
INTEREST COVERAGE RATIO
-1.66x
INTEREST COVERAGE RATIO AVG TTM
N/A
INTEREST COVERAGE RATIO AVG 3Y
-132.39x
INTEREST COVERAGE RATIO AVG 5Y
-172.48x
INTEREST COVERAGE RATIO AVG 10Y
-149.27x
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
+98.75%
CURRENT VS 5Y AVG
+99.04%
CURRENT VS 10Y AVG
+98.89%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.31x
median of 507 covered companies
CURRENT VS SECTOR MEDIAN
+73.69%
vs the sector median at left
Entera Bio Ltd.
Market Cap
$126.51M
Interest Coverage Ratio
-1.66x
TTM Avg
N/A
3Y Avg
-132.39x
5Y Avg
-172.48x
Market Cap
$126.21M
Interest Coverage Ratio
-24.18x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$124.98M
Interest Coverage Ratio
-1412.39x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$130.75M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$121.68M
Interest Coverage Ratio
-50.85x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$120.58M
Interest Coverage Ratio
-41.14x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$120.52M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Entera Bio Ltd. (ENTX) | $126.51M | -1.66x | N/A | -132.39x | -172.48x |
| NRx Pharmaceuticals, Inc. (NRXP)vs › | $126.21M | -24.18x | N/A | N/A | N/A |
| Tonix Pharmaceuticals Holding Corp. (TNXP)vs › | $124.98M | -1412.39x | N/A | N/A | N/A |
| Pyxis Oncology, Inc. (PYXS)vs › | $130.75M | N/A | N/A | N/A | N/A |
| TuHURA Biosciences, Inc. (HURA)vs › | $121.68M | -50.85x | N/A | N/A | N/A |
| Seer, Inc. (SEER)vs › | $121.23M | N/A | N/A | N/A | N/A |
| Cibus, Inc. (CBUS)vs › | $120.60M | -1.90x | N/A | N/A | N/A |
| enGene Holdings Inc. (ENGN)vs › | $120.58M | -41.14x | N/A | N/A | N/A |
| Tenaya Therapeutics, Inc. (TNYA)vs › | $120.52M | N/A | N/A | N/A | N/A |
| Health Catalyst, Inc. (HCAT)vs › | $132.64M | -2.20x | N/A | N/A | N/A |
Interest Coverage
-1.7x
Debt/Equity
0.06
Current Ratio
8.98
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -1.66x |
| 2024-12-31 | -333.86x |
| 2023-12-31 | -61.66x |
| 2022-09-30 | -358.13x |
| 2021-06-30 | -107.08x |
| 2020-12-31 | -45.90x |
| 2020-09-30 | -185.85x |
| 2020-06-30 | -121.62x |
| 2019-12-31 | -218.44x |
| 2019-09-30 | -86.03x |
| 2019-06-30 | -106.79x |
| 2019-03-31 | -193.19x |
| 2018-09-30 | -124.61x |
| 2018-03-31 | -207.80x |
| 2017-06-30 | -374.13x |
| 2016-09-30 | -4.72x |
| 2016-06-30 | -6.11x |
